Jane Street Group, LLC Atara Biotherapeutics, Inc. Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.44 - $1.22 $30,591 - $84,821	-69,526 Reduced 52.6%	62,651 $43,000
Q4 2023 Feb 14, 2024	BUY	$0.23 - $1.74 $25,017 - $189,265	108,773 Added 464.76%	132,177 $67,000
Q3 2023 Nov 14, 2023	SELL	$1.41 - $2.31 $589,897 - $966,427	-418,367 Reduced 94.7%	23,404 $34,000
Q2 2023 Aug 14, 2023	BUY	$1.5 - $3.04 $635,271 - $1.29 Million	423,514 Added 2319.73%	441,771 $711,000
Q1 2023 May 15, 2023	SELL	$2.8 - $5.46 $363,300 - $708,435	-129,750 Reduced 87.66%	18,257 $52,000
Q4 2022 Feb 14, 2023	BUY	$2.85 - $5.18 $199,765 - $363,081	70,093 Added 89.96%	148,007 $485,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $150,388 - $460,664	52,768 Added 209.85%	77,914 $295,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $150,388 - $460,664	52,768 Added 209.85%	77,914 $295,000
Q2 2022 Aug 16, 2022	BUY	$4.69 - $9.84 $56,158 - $117,824	11,974 Added 90.9%	25,146 $195,000
Q4 2021 Feb 15, 2022	SELL	$14.7 - $19.89 $154,379 - $208,884	-10,502 Reduced 44.36%	13,172 $208,000
Q3 2021 Nov 16, 2021	BUY	$11.99 - $17.9 $106,639 - $159,202	8,894 Added 60.18%	23,674 $424,000
Q2 2021 Aug 16, 2021	SELL	$12.89 - $16.58 $91,712 - $117,966	-7,115 Reduced 32.5%	14,780 $229,000
Q1 2021 May 18, 2021	SELL	$14.0 - $20.72 $120,162 - $177,839	-8,583 Reduced 28.16%	21,895 $314,000
Q4 2020 Feb 17, 2021	SELL	$12.67 - $26.23 $983,838 - $2.04 Million	-77,651 Reduced 71.81%	30,478 $598,000
Q3 2020 Nov 17, 2020	BUY	$11.92 - $15.87 $1.09 Million - $1.45 Million	91,115 Added 535.53%	108,129 $1.4 Million
Q2 2020 Aug 17, 2020	BUY	$7.53 - $14.93 $128,115 - $254,019	17,014 New	17,014 $248,000
Q1 2020 May 15, 2020	SELL	$5.69 - $17.78 $323,391 - $1.01 Million	-56,835 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$10.89 - $16.79 $375,127 - $578,365	34,447 Added 153.86%	56,835 $936,000
Q3 2019 Nov 14, 2019	BUY	$12.03 - $19.94 $269,327 - $446,416	22,388 New	22,388 $316,000

Others Institutions Holding ATRA

# of Institutions

Shares Held

2.89M

Call Options Held

Put Options Held

View Full List

About Atara Biotherapeutics, Inc.

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

More about ATRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account